CAR‐NK cell in cancer immunotherapy; A promising frontier F Marofi, OF Abdul‐Rasheed, HS Rahman, HS Budi, AT Jalil, ... Cancer Science 112 (9), 3427-3436, 2021 | 192 | 2021 |
CAR T cells targeting the tumor MUC1 glycoprotein reduce triple-negative breast cancer growth R Zhou, M Yazdanifar, LD Roy, LM Whilding, A Gavrill, J Maher, ... Frontiers in immunology 10, 1149, 2019 | 148 | 2019 |
γδ T Cells: The Ideal Tool for Cancer Immunotherapy M Yazdanifar, G Barbarito, A Bertaina, I Airoldi Cells 9 (5), 1305, 2020 | 111 | 2020 |
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies E Razeghian, MKM Nasution, HS Rahman, ZR Gardanova, ... Stem cell research & therapy 12, 1-17, 2021 | 90 | 2021 |
CAR-NK cell: a new paradigm in tumor immunotherapy F Marofi, AS Al-Awad, HS Rahman, A Markov, WK Abdelbasset, YI Enina, ... Frontiers in oncology 11, 2021 | 80 | 2021 |
A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis R Zhou, JM Curry, LD Roy, P Grover, J Haider, LJ Moore, ST Wu, ... Oncogene 35 (43), 5608-5618, 2016 | 65 | 2016 |
Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells F Morandi*, M Yazdanifar*, C Cocco, A Bertaina, I Airoldi Cells 9 (8), 1757, 2020 | 59 | 2020 |
Overcoming Immunological Resistance Enhances the Efficacy of a Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma M Yazdanifar, R Zhou, P Grover, C Williams, M Bose, LJ Moore, S Wu, ... Cells 8 (9), 1070, 2019 | 56 | 2019 |
CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies F Marofi, MM Saleh, HS Rahman, W Suksatan, ME Al-Gazally, ... Stem cell research & therapy 12 (1), 374, 2021 | 48 | 2021 |
Evaluation of cytokines in multiple sclerosis patients treated with mesenchymal stem cells MM Bonab, M Mohajeri, MA Sahraian, M Yazdanifar, A Aghsaie, ... Archives of Medical Research 44 (4), 266-272, 2013 | 41 | 2013 |
A deep insight into CAR-T cell therapy in non-Hodgkin lymphoma: application, opportunities, and future directions F Marofi, HS Rahman, MH Achmad, KN Sergeevna, W Suksatan, ... Frontiers in immunology 12, 2021 | 40 | 2021 |
Hurdles to breakthrough in CAR T cell therapy of solid tumors F Marofi, H Achmad, D Bokov, WK Abdelbasset, Z Alsadoon, S Chupradit, ... Stem Cell Research & Therapy 13 (1), 140, 2022 | 31 | 2022 |
Harnessing TRAIL-induced apoptosis pathway for cancer immunotherapy and associated challenges E Razeghian, W Suksatan, HS Rahman, DO Bokov, WK Abdelbasset, ... Frontiers in immunology 12, 2021 | 30 | 2021 |
Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles S Wu, AJ Fowler, CB Garmon, AB Fessler, JD Ogle, KR Grover, BC Allen, ... BMC cancer 18, 1-13, 2018 | 29 | 2018 |
Mesenchymal stem/stromal cells as a vehicle for cytokine delivery: an emerging approach for tumor immunotherapy E Razeghian, R Margiana, S Chupradit, DO Bokov, WK Abdelbasset, ... Frontiers in medicine 8, 2021 | 27 | 2021 |
Antibody-guided in vivo imaging for early detection of mammary gland tumors LJ Moore, LD Roy, R Zhou, P Grover, S Wu, JM Curry, LM Dillon, PM Puri, ... Translational Oncology 9 (4), 295-305, 2016 | 27 | 2016 |
Induced pluripotent stem cells (iPSCs) provide a potentially unlimited T cell source for CAR-T cell development and off-the-shelf products M Sadeqi Nezhad, M Abdollahpour-Alitappeh, B Rezaei, M Yazdanifar, ... Pharmaceutical Research 38 (6), 931-945, 2021 | 26 | 2021 |
Making a case for using γδ T cells against SARS-CoV-2 M Yazdanifar, N Mashkour, A Bertaina Critical Reviews in Microbiology 46 (4), 2020 | 23 | 2020 |
Mesenchymal stem/stromal cell-based delivery: a rapidly evolving strategy for cancer therapy A Hassanzadeh, AH Altajer, HS Rahman, MM Saleh, DO Bokov, ... Frontiers in Cell and Developmental Biology 9, 2021 | 21 | 2021 |
Emerging immunotherapeutics in adenocarcinomas: A focus on CAR-T cells M Yazdanifar, R Zhou, P Mukherjee Current Trends in Immunology 17, 2016 | 21 | 2016 |